- Report
- November 2023
- 80 Pages
Global
From €3957EUR$4,500USD£3,417GBP
- Report
- May 2023
- 526 Pages
Global
From €3671EUR$4,175USD£3,170GBP
- Report
- January 2025
- 132 Pages
Global
From €835EUR$950USD£721GBP
The ELISpot Assay is a type of in vitro diagnostic test used to measure the frequency of antigen-specific cells in a sample. It is a powerful tool for measuring the immune response to a particular antigen, and is used in a variety of applications, including vaccine development, cancer immunotherapy, and autoimmune disease diagnosis. The ELISpot Assay market is a rapidly growing segment of the in vitro diagnostics industry, driven by the increasing demand for more accurate and reliable diagnostic tests. The assay is also becoming increasingly popular due to its ability to detect low levels of antigen-specific cells, and its ability to provide quantitative results.
Notable companies in the ELISpot Assay market include Merck, Bio-Rad, PerkinElmer, and U-Cytech. Show Less Read more